HOFMANN LA ROCHE AG F has a total of 24 patent applications. Its first patent ever was published in 1985. It filed its patents most often in Yugoslavia (Serbia and Montenegro), China and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are IDUN PHARMACEUTICALS INC, ABBVIE DEUTSCHLAND and AN2H DISCOVERY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Yugoslavia (Serbia and Montenegro) | 6 | |
#2 | China | 3 | |
#3 | Republic of Korea | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Brazil | 2 | |
#6 | Colombia | 2 | |
#7 | Slovenia | 2 | |
#8 | Romania | 1 | |
#9 | Singapore | 1 | |
#10 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement | |
#4 | Biotechnology | |
#5 | Medical technology | |
#6 | Micro-structure and nano-technology | |
#7 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Hahn Susan E | 2 |
#2 | Findlay Helen P | 2 |
#3 | Young David S F | 2 |
#4 | Stalder Henri | 2 |
#5 | Ishitsuka Hideo | 1 |
#6 | Davey P T | 1 |
#7 | Hartman D | 1 |
#8 | Klaus M | 1 |
#9 | Dott C S | 1 |
#10 | Boka Chris Allen | 1 |
Publication | Filing date | Title |
---|---|---|
ZA200104275B | 4-alkenyl (and alkynyl) oxindoles as inhibitors of cyclin-dependent kinases, in particular CDK2. | |
CN1265656A | O-substituted hydroxycumaranone derivatives as anttumor and antimetastatic agents | |
SI8510744A8 | Cephalosporines derivates and process for preparing them |